Journal Section:
Erratum

In the article “A Novel Pathogenic Variant in the CABP2 Gene Causes Severe Nonsyndromic Hearing Loss in a Consanguineous Iranian Family” [Audiol Neurotol. 2019;24:258–63. DOI: 10.1159/000502251] by Koohiyan et al., an error occurred during choosing the image and merging the sequencing figures of family members. Mistakenly, the authors selected the same image for both parents in Figure 1b “Sequencing results of the variant.” As the error was only in the image, the meaning of the image and the results of the article remain unchanged.

The corrected Figure 1b is shown here:

Fig. 1.
a Pedigree and segregation of the p.Gly104Asp variant in the ISF-13 family. The affected individual sequenced with WES is indicated with an arrow. b Sequencing results of the variant. c Right and left ear audiograms in patient V: 2. d Multiple amino acid alignment of protein homologs was conserved.
View largeDownload slide

a Pedigree and segregation of the p.Gly104Asp variant in the ISF-13 family. The affected individual sequenced with WES is indicated with an arrow. b Sequencing results of the variant. c Right and left ear audiograms in patient V: 2. d Multiple amino acid alignment of protein homologs was conserved.

Fig. 1.
a Pedigree and segregation of the p.Gly104Asp variant in the ISF-13 family. The affected individual sequenced with WES is indicated with an arrow. b Sequencing results of the variant. c Right and left ear audiograms in patient V: 2. d Multiple amino acid alignment of protein homologs was conserved.
View largeDownload slide

a Pedigree and segregation of the p.Gly104Asp variant in the ISF-13 family. The affected individual sequenced with WES is indicated with an arrow. b Sequencing results of the variant. c Right and left ear audiograms in patient V: 2. d Multiple amino acid alignment of protein homologs was conserved.

Close modal
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025